AXM Pharma Statistics
Total Valuation
AXM Pharma has a market cap or net worth of 10,409.
| Market Cap | 10,409 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AXM Pharma has 10.41 billion shares outstanding.
| Current Share Class | 10.41B |
| Shares Outstanding | 10.41B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.00.
| PE Ratio | 0.00 |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.70, with a Debt / Equity ratio of 0.63.
| Current Ratio | 0.70 |
| Quick Ratio | 0.14 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 25.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -119.94 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 45.37 |
| Average Volume (20 Days) | 13,250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, AXM Pharma had revenue of 110.68 million and earned 8.35 million in profits. Earnings per share was 0.00.
| Revenue | 110.68M |
| Gross Profit | 20.77M |
| Operating Income | 12.46M |
| Pretax Income | 11.91M |
| Net Income | 8.35M |
| EBITDA | n/a |
| EBIT | 12.46M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.66 million in cash and 29.33 million in debt, giving a net cash position of -27.67 million or -0.00 per share.
| Cash & Cash Equivalents | 1.66M |
| Total Debt | 29.33M |
| Net Cash | -27.67M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 46.56M |
| Book Value Per Share | 0.01 |
| Working Capital | -16.39M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 18.77%, with operating and profit margins of 11.26% and 7.54%.
| Gross Margin | 18.77% |
| Operating Margin | 11.26% |
| Pretax Margin | 10.76% |
| Profit Margin | 7.54% |
| EBITDA Margin | n/a |
| EBIT Margin | 11.26% |
| FCF Margin | n/a |
Dividends & Yields
AXM Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 80,217.57% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXM Pharma has an Altman Z-Score of 1.77. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.77 |
| Piotroski F-Score | n/a |